Selective Invasive Treatment Best for Women with Non-ST Elevation Acute Coronary Syndromes
Eva Swahn
REFERENCE: HOTLINE II, Monday 8am, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
EVA SWAHN, University Hospital Linköping, Sweden
COMMENT: ECKART FLECK, Deutsches Herzzentrum, Berlin
Women who undergo selective invasive treatment for non-ST elevation acute coronary syndromes do better than those who receive routine early invasive treatment. This is according to the OASIS 5 study from Sweden that randomised women to either of the two approaches. The findings suggest that females with non-ST elevation ACS should be approached differently from their male counterparts. Sarah Maxwell interviewed OASIS investigator Eva Swahn at the ESC meeting in Vienna. Eckart Fleck of the Deutsches Herzzentrum in Berlin gave his comments on her comments to Derek Thorne.
EVA SWAHN, University Hospital Linköping, Sweden
COMMENT: ECKART FLECK, Deutsches Herzzentrum, Berlin
Women who undergo selective invasive treatment for non-ST elevation acute coronary syndromes do better than those who receive routine early invasive treatment. This is according to the OASIS 5 study from Sweden that randomised women to either of the two approaches. The findings suggest that females with non-ST elevation ACS should be approached differently from their male counterparts. Sarah Maxwell interviewed OASIS investigator Eva Swahn at the ESC meeting in Vienna. Eckart Fleck of the Deutsches Herzzentrum in Berlin gave his comments on her comments to Derek Thorne.
